-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 17, Simcere announced the appointment of Zhou Gaobo as chief investment officer, responsible for the company's innovative drug investment and business expansion, new investment platform construction, and strategic planning and practice.
He took office on the same day
.
Before joining Simcere, Mr.
Gaobo Zhou served as a global managing partner and co-head of Greater China Healthcare Consulting at McKinsey & Company, and has fifteen years of experience in management consulting in the healthcare industry
.
Previously, he also worked on antibody and fusion protein drug development at Human Genome Sciences (HGSI)
Mr.